Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing
- 16 April 2011
- journal article
- review article
- Published by Elsevier BV in Acta Tropica
- Vol. 119 (1), 5-10
- https://doi.org/10.1016/j.actatropica.2011.04.008
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosisJournal of Medical Microbiology, 2011
- Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in JapanClinical Microbiology & Infection, 2010
- Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysisBMC Infectious Diseases, 2009
- Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosisclinical strains segregated by spoligotype families from tuberculosis prevalent countries in South AmericaBMC Microbiology, 2009
- Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South AfricaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular PerspectiveAntimicrobial Agents and Chemotherapy, 2002
- Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosisProceedings of the National Academy of Sciences, 2000
- pncA Mutations as a Major Mechanism of Pyrazinamide Resistance in Mycobacterium tuberculosis : Spread of a Monoresistant Strain in Quebec, CanadaAntimicrobial Agents and Chemotherapy, 2000
- Mechanisms of Isoniazid Resistance inMycobacterium tuberculosis:Enzymatic Characterization of Enoyl Reductase Mutants Identified in Isoniazid‐Resistant Clinical IsolatesThe Journal of Infectious Diseases, 1998
- Mechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1998